SCHEMBL25350232

SCHEMBL25350232

FC(F)c1nnc(-c2ccc(Cn3cc(-c4ccc5cc[nH]c5c4)nn3)cc2)o1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 6/20 0.57
▸ ROCK2 O75116 9/20 0.45
▸ GSK3B P49841 8/20 0.45
▸ CDC7 O00311 5/20 0.45
▸ PIM1 P11309 6/20 0.44
▸ AURKB Q96GD4 6/20 0.44
▸ KDR P35968 3/20 0.44
▸ CDK2 P24941 4/20 0.42
▸ PRKACA P17612 3/20 0.42
▸ JAK2 O60674 3/20 0.42
▸ AURKA O14965 2/20 0.42
▸ CHUK O15111 2/20 0.42
▸ MAPK13 O15264 2/20 0.42
▸ DAPK3 O43293 2/20 0.42
▸ CHEK2 O96017 2/20 0.42
▸ PRKCG P05129 2/20 0.42
▸ CDK1 P06493 2/20 0.42
▸ FGFR1 P11362 2/20 0.42
▸ MARK3 P27448 2/20 0.42
▸ MAPK1 P28482 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25351569 0.92 HDAC6 (0.55) HDAC6ROCK2GSK3BCDC7PIM1
SCHEMBL25352046 0.87 HDAC6 (0.52) HDAC6ROCK2GSK3BPIM1AURKB
SCHEMBL25351024 0.87 HDAC6 (0.44) HDAC6ROCK2GSK3BPIM1AURKB
SCHEMBL30425892 0.86 ROCK2 (0.58) HDAC6ROCK2GSK3BCDC7PIM1
SCHEMBL25268143 0.86 ROCK2 (0.58) HDAC6ROCK2GSK3BCDC7PIM1
SCHEMBL25352086 0.85 HDAC6 (0.53) HDAC6ROCK2GSK3BCDC7PIM1
SCHEMBL25351284 0.85 HDAC6 (0.54) HDAC6ROCK2GSK3BCDC7PIM1
SCHEMBL30409501 0.85 HDAC6 (0.55) HDAC6ROCK2GSK3BCDC7PIM1
SCHEMBL25352268 0.84 HDAC6 (0.42) HDAC6ROCK2GSK3BCDC7PIM1
SCHEMBL25251038 0.83 HDAC6 (0.53) HDAC6ROCK2GSK3BCDC7PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME HDAC6, HDAC1, HDAC3 HDAC6 1/4885ROCK2 2366/4885GSK3B 192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback